Mingjian James You (M James You, M James You)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Topics

Prognostic Factors

Diffuse Large B Cell Lymphoma

Top Venues

Cancer discovery

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Devin Wang, Wataru Kamata, Fengxi Ye, Mingjian James You
From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1 + B-Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution. EJHaem 5 (1) (2024)
Guang Lei, Chao Mao, Amber D Horbath, Yuelong Yan, Shirong Cai, Yao Jun, Yan Jiang, Mingchuang Sun, Xiaoguang Liu, Jun Cheng, Zhihao Xu, Hyemin Lee, Qidong Li, Zhengze Lu, Li Zhuang, Mei-Kuang Chen, Anagha Alapati, Timothy Anthony Yap, Mien-Chie Hung, Mingjian James You, Helen Piwnica-Worms, Boyi Gan
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer discovery 14 (8) (2024)
Guang Lei, Chao Mao, Amber D Horbath, Yuelong Yan, Shirong Cai, Yao Jun, Yan Jiang, Mingchuang Sun, Xiaoguang Liu, Jun Cheng, Zhihao Xu, Hyemin Lee, Qidong Li, Zhengze Lu, Li Zhuang, Mei-Kuang Chen, Anagha Alapati, Timothy Anthony Yap, Mien-Chie Hung, Mingjian James You, Helen Piwnica-Worms, Boyi Gan
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer discovery 14 (8) (2024)
Devin Wang, Wataru Kamata, Fengxi Ye, Mingjian James You
From primary myelofibrosis to chronic myeloid leukemia, BCR::ABL1 + B-Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolution. EJHaem 5 (1) (2024)
Matthew T Ye, Zhuang Zuo, Steliana Calin, Fengxi Ye, Hua He, Wataru Kamata, Yaling Yang, Mingjian James You
Integrated Clinical Genotype-phenotype Characteristics of STAT3-mutated Myeloid Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Guang Lei, Chao Mao, Amber D Horbath, Yuelong Yan, Shirong Cai, Yao Jun, Yan Jiang, Mingchuang Sun, Xiaoguang Liu, Jun Cheng, Zhihao Xu, Hyemin Lee, Qidong Li, Zhengze Lu, Li Zhuang, Mei-Kuang Chen, Anagha Alapati, Timothy Anthony Yap, Mien-Chie Hung, Mingjian James You, Helen Piwnica-Worms, Boyi Gan
BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers. Cancer discovery (2024)
Qiudan Shen, Elias J Jabbour, Guillin Tang, Hong Fang, Wei Wang, Nicholas James Short, Mingjian James You, L Jeffrey Medeiros, Shimin Hu
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia. American journal of hematology (2024)
Guang Lei, Chao Mao, Amber D Horbath, Yuelong Yan, Shirong Cai, Yao Jun, Yan Jiang, Mingchuang Sun, Xiaoguang Liu, Jun Cheng, Zhihao Xu, Hyemin Lee, Qidong Li, Zhengze Lu, Li Zhuang, Mei-Kuang Chen, Anagha Alapati, Timothy Anthony Yap, Mien-Chie Hung, Mingjian James You, Helen Piwnica-Worms, Boyi Gan
BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers. Cancer discovery (2024)
Guang Lei, Chao Mao, Amber D Horbath, Yuelong Yan, Shirong Cai, Yao Jun, Yan Jiang, Mingchuang Sun, Xiaoguang Liu, Jun Cheng, Zhihao Xu, Hyemin Lee, Qidong Li, Zhengze Lu, Li Zhuang, Mei-Kuang Chen, Anagha Alapati, Timothy Anthony Yap, Mien-Chie Hung, Mingjian James You, Helen Piwnica-Worms, Boyi Gan
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer discovery 14 (8) (2024)
Nianyi Li, Pei Lin, Zhuang Zuo, Mingjian James You, Wen Shuai, Robert Orlowski, Elisabet E Manasanch, Shaoying Li, Jie Xu, Sofia Garces, Fatima Zahra Jelloul, Zhenya Tang, Wei Wang, L Jeffrey Medeiros, Cheng Cameron Yin
Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. Cancer medicine (2023)
Fatima Zahra Jelloul, Mark J Routbort, Courtney D D DiNardo, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamana, Beenu Thakral, Zhuang Zuo, Cheng Cameron Yin, Sanam Loghavi, Chi Young Ok, Sa A Wang, Zhenya Tang, Mingjian James You, Keyur P Patel, L Jeffrey Medeiros, Andrés E Quesada
DDX41 mutations in patients with non-myeloid hematologic neoplasms. American journal of hematology (2023)
Hong Fang, Hannah C Beird, Sa A Wang, Andrew F Ibrahim, Zhenya Tang, Guillin Tang, Mingjian James You, Shimin Hu, Jie Xu, Shaoying Li, C Cameron Yin, Siba El Hussein, Nhi Le, P Andrew Futreal, Carlos Bueso-Ramos, Beenu Thakral, Tapan Mahendra Kadia, Rebecca Thornton, Latasha Little, Curtis Gumbs, Xingzhi Song, L Jeffrey Medeiros, Wei Wang
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia (2023)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Wen Shuai, Zhuang Zuo, Nianyi Li, Sofia Garces, Fatima Zahra Jelloul, Chi Young Ok, Shaoying Li, Jie Xu, Mingjian James You, Wei Wang, Catherine Rehder, Elias J Jabbour, Keyur P Patel, L Jeffrey Medeiros, Cheng Cameron Yin
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129 (6) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Junhua Lyu, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F Madanat, Yuannyu Zhang, Feng Cai, Zhimin Gu, Hui Cao, Pranita Kaphle, Yoon Jung Kim, Fatma N Kalkan, Helen Stephens, Kathryn E Dickerson, Min Ni, Weina Chen, Prapti A Patel, Alice S Mims, Uma Borate, Amy Burd, Sheng F Cai, Cheng Cameron Yin, Mingjian James You, Stephen S Chung, Robert H Collins, Ralph J DeBerardinis, Xin Liu, Jian Xu
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance. Cancer discovery (2022)
Matthew T Ye, Yi Wang, Zhuang Zuo, Steliana Calin, Hua He, Zhenya Tang, Elias J Jabbour, Gautam Borthakur, Yizhuo Zhang, Yaling Yang, Mingjian James You
Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia. Cancer (2022)
Wen Shuai, Zhuang Zuo, Nianyi Li, Sofia Garces, Fatima Zahra Jelloul, Chi Young Ok, Shaoying Li, Jie Xu, Mingjian James You, Wei Wang, Catherine Rehder, Elias J Jabbour, Keyur P Patel, L Jeffrey Medeiros, Cheng Cameron Yin
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129 (6) (2022)
Sujan Piya, Yaling Yang, Seemana Bhattacharya, Priyanka Sharma, Huaxian Ma, Hong Mu, Hua He, Vivian Ruvolo, Natalia Baran, Richard Eric Davis, Abhinav K Jain, Marina Y Konopleva, Hagop M Kantarjian, Michael Andreeff, Mingjian James You, Gautam Borthakur
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL. Leukemia 36 (5) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia (2022)
Wen Shuai, Zhuang Zuo, Nianyi Li, Sofia Garces, Fatima Zahra Jelloul, Chi Young Ok, Shaoying Li, Jie Xu, Mingjian James You, Wei Wang, Catherine Rehder, Elias J Jabbour, Keyur P Patel, L Jeffrey Medeiros, Cheng Cameron Yin
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129 (6) (2022)
Wen Shuai, Zhuang Zuo, Nianyi Li, Sofia Garces, Fatima Zahra Jelloul, Chi Young Ok, Shaoying Li, Jie Xu, Mingjian James You, Wei Wang, Catherine Rehder, Elias J Jabbour, Keyur P Patel, L Jeffrey Medeiros, Cheng Cameron Yin
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer (2022)